Impact of the COVID‐19 pandemic on the incidence of dengue fever in Peru

Plasencia-Duenas, Rubi; Failoc‐Rojas, Virgilio E.; Rodríguez‐Morales, Alfonso J.

doi:10.1002/jmv.27298

Cited by 15 publications

(11 citation statements)

References 15 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 3 The high burden of dengue and COVID‐19 infections increases the possibility of co‐infection, which is a significant health concern due to the overlapped symptomatology and similar laboratory findings of the two conditions in dengue‐endemic regions. 4 , 5 This overlap would make reaching the correct diagnosis and, subsequently, the proper management challenging for both diseases. 5 Furthermore, there are previous studies about the co‐infection of dengue and COVID‐19 during the current pandemic, with reported worse clinical manifestations and higher complications.…”

Section: Introductionmentioning

confidence: 99%

“…In addition, approximately more than 400 million cases are infected with dengue fever each year, transmitted by the Aedes aegypti mosquito 3 . The high burden of dengue and COVID‐19 infections increases the possibility of co‐infection, which is a significant health concern due to the overlapped symptomatology and similar laboratory findings of the two conditions in dengue‐endemic regions 4,5 . This overlap would make reaching the correct diagnosis and, subsequently, the proper management challenging for both diseases 5 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Does dengue and COVID‐19 co‐infection have worse outcomes? A systematic review of current evidence

El‐Qushayri

Kamel

Reda

et al. 2022

Reviews in Medical Virology

View full text Add to dashboard Cite

In dengue‐endemic regions, the co‐infection with SARS‐CoV‐2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID‐19 co‐infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID‐19 and dengue co‐infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise‐decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Does dengue and COVID‐19 co‐infection have worse outcomes? A systematic review of current evidence

El‐Qushayri

Kamel

Reda

et al. 2022

Reviews in Medical Virology

View full text Add to dashboard Cite

show abstract

“…and Plasencia et al. ( Lim et al., 2020 ; Plasencia-Dueñas et al., 2021 ) with data collection period of less than two years in non-exposed group(COVID-19 pre-pandemic) were selected for comparison with the article that had the same study site and analytic methods but a longer data collection period in non-exposed group. A subgroup meta-analysis revealed that the pooled RR value in the study with less than two years of observation in the control group was overestimated ( Supplementary Figure 1 ).…”

Section: Resultsmentioning

confidence: 99%

Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis

Dong

et al. 2022

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Non-pharmacological interventions (NPIs) implemented during the coronavirus disease 2019 (COVID-19) pandemic have demonstrated significant positive effects on other communicable diseases. Nevertheless, the response for dengue fever has been mixed. To illustrate the real implications of NPIs on dengue transmission and to determine the effective measures for preventing and controlling dengue, we performed a systematic review and meta-analysis of the available global data to summarize the effects comprehensively. We searched Embase, PubMed, and Web of Science in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines from December 31, 2019, to March 30, 2022, for studies of NPI efficacy on dengue infection. We obtained the annual reported dengue cases from highly dengue-endemic countries in 2015–2021 from the European Centre for Disease Prevention and Control to determine the actual change in dengue cases in 2020 and 2021, respectively. A random-effects estimate of the pooled odds was generated with the Mantel-Haenszel method. Between-study heterogeneity was assessed using the inconsistency index (I2) and subgroup analysis according to country (dengue-endemic or non-endemic) was conducted. This review was registered with PROSPERO (CRD42021291487). A total of 17 articles covering 32 countries or regions were included in the review. Meta-analysis estimated a pooled relative risk of 0.39 (95% CI: 0.28–0.55), and subgroup revealed 0.06 (95% CI: 0.02-0.25) and 0.55 (95% CI: 0.44-0.68) in dengue non-endemic areas and dengue-endemic countries, respectively, in 2020. The majority of highly dengue-endemic countries in Asia and Americas reported 0–100% reductions in dengue cases in 2020 compared to previous years, while some countries (4/20) reported a dramatic increase, resulting in an overall increase of 11%. In contrast, there was an obvious reduction in dengue cases in 2021 in almost all countries (18/20) studied, with an overall 40% reduction rate. The overall effectiveness of NPIs on dengue varied with region and time due to multiple factors, but most countries reported significant reductions. Travel-related interventions demonstrated great effectiveness for reducing imported cases of dengue fever. Internal movement restrictions of constantly varying intensity and range are more likely to mitigate the entire level of dengue transmission by reducing the spread of dengue fever between regions within a country, which is useful for developing a more comprehensive and sustainable strategy for preventing and controlling dengue fever in the future.

show abstract

“…In addition to the COVID-19-related unprecedented situation, dengue would retain its epidemic status in most resource-constrained countries of Asia and Latin America. Indeed, control measures of dengue infection are neglected in many epidemic countries as excessive prioritization is given to preventing and control of SARS-CoV-2 infections [ 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic

Khan

Akbar

Yahiro

et al. 2022

IJERPH

View full text Add to dashboard Cite

The outbreak of coronavirus disease 2019 (COVID-19) devastated the overall health management strategy of most countries. In this scenario, the present study provided insights into the possible impact of the COVID-19 pandemic on dengue infection. This ecological study retrieved data from WHO/Government reporting system from 22 major dengue epidemic countries. Incidence of dengue infections during the pre-COVID-19 time (2015~2019) and COVID-19 period (2020~2021) was compared. A correlation between the dengue and COVID-19 cases and predicted dengue incidence in 2022 was calculated using the linear regression equation. Data indicated that dengue incidences across the studied area decreased by 16% during the pandemic period (2.73 million vs. 2.29 million; p < 0.05) than the same reported in pre-COVID-19 time. Although countries in Latin America reported more cases than Asia, a positive correlation (r = 0.83) between dengue and COVID-19 cases was observed in Asia. Prediction analysis warned that specific preparation for dengue management is needed in some countries of both regions in 2022 to contain the upsurge in incidences. Due to the similar nature of symptoms of dengue and COVID-19, a state of confusion will be prevailing during the ongoing pandemic. Therefore, comprehensive and evidence-based scientific approaches were warranted at all levels.

show abstract

Impact of the COVID‐19 pandemic on the incidence of dengue fever in Peru

Cited by 15 publications

References 15 publications

Does dengue and COVID‐19 co‐infection have worse outcomes? A systematic review of current evidence

Does dengue and COVID‐19 co‐infection have worse outcomes? A systematic review of current evidence

Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis

Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic

Contact Info

Product

Resources

About